Marry Van Den Heuvel-Eibrink

Princess Máxima Center Netherlands

The group of Prof. Dr. van den Heuvel-Eibrink focus on the identification of (genetic) determinants of early and late toxicity of childhood cancer, especially endocrine sequelae, and ototoxicity. Research projects are specifically focused on frailty, osteoporosis, fertility and ototoxicity, including tinnitus and hearing loss. The study results contribute to development of international surveillance guideline and intervention studies. In addition to toxicity following childhood cancer, Prof. Dr. van den Heuvel-Eibrink is involved in the outpatient expertise center on Cancer In Pregnancy (CIP), aiming to develop clinical guidelines, so physicians can treat pregnant women with a cancer diagnosis more targeted, and reduce its possible effects on the child’s outcome.

Marry Van Den Heuvel-Eibrink

1chapters authored